EP #432: The View from the Jumbo Group Market — Greg Baker

In this week's episode, EmsanaRx, PBC CEO Greg Baker gives us a bird's-eye view of the healthcare system. Find out what issues jumbo organizations are having and how the PBM is contributing to them. He also discusses EmsanaRx's efforts to break the cycle by developing PBMs that are committed to serving the general welfare while establishing incentives that make sense for PBMs, clients, and members.What You’ll Learn From This Episode:1:22 Greg’s realization of the bigger issues that needed to be addressed after analyzing the PBM contracts and data from large organizations.3:15 The issue with most healthcare systems operated by for-profit businesses.5:33 The role PBMs play in drug approval: part of the reason switching to generic medications hasn't been able to solve the issue.9:45 How they are developing a PBM that is not motivated by profit but by the public good in order to drive clinical experience and outcome.14:14 Partnership with Cleveland: Creating formularies that truly benefit patients. 17:54 Creating incentives that make sense to PBMs, clients, and members by separating fulfillment.Enjoy The Show?Don't miss an episode, subscribe via iTunes, Stitcher or RSS.Leave us a review in iTunes (here's how)Join the conversation by leaving a comment below!